Finance

Lists
Why is 600613 down 3.47%?
Dive Deeper
600613:SHA
Shanghai Shenqi Pharmaceutical Investment Management Ord Shs A
CNÂ¥5.56
-3.47%
(-0.20) 1D
Nov 19, 3:00:02 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 600613...
Open
CNÂ¥5.75
High
CNÂ¥5.76
Low
CNÂ¥5.53
Mkt. cap
2.90B
Avg. vol.
45.04M
Volume
15.98M
Dividend
1.26%
Quarterly dividend
CNÂ¥0.02
Ex-dividend date
Jun 17, 2026
P/E ratio
343.42
52-wk high
CNÂ¥12.77
52-wk low
CNÂ¥4.33
EPS
CNÂ¥0.02
Shares outstanding
479.32M
No. of employees
1K
Open
CNÂ¥5.75
High
CNÂ¥5.76
Low
CNÂ¥5.53
Mkt. cap
2.90B
Avg. vol.
45.04M
Volume
15.98M
Dividend
1.26%
Quarterly dividend
CNÂ¥0.02
Ex-dividend date
Jun 17, 2026
P/E ratio
343.42
52-wk high
CNÂ¥12.77
52-wk low
CNÂ¥4.33
EPS
CNÂ¥0.02
Shares outstanding
479.32M
No. of employees
1K
News stories
From web sources and news partners
About Shanghai Shenqi Pharmaceutical Investment Management Ord Shs A
CEO-
Employees1.2K
FoundedJul 22, 1992
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websitegzsq.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
554.51M
422.94M
425.19M
401.31M
Cost of goods sold
348.47M
232.06M
255.15M
207.90M
Cost of revenue
348.47M
232.06M
255.15M
207.90M
Research and development expenses
8.48M
7.04M
7.68M
4.87M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
186.17M
148.02M
136.08M
162.34M
Operating expense
211.87M
169.08M
148.61M
175.69M
Total operating expenses
560.34M
401.14M
403.76M
383.59M
Operating income
-5.83M
21.80M
21.43M
17.72M
Other non operating income
-1.07M
-1.84M
-340.06K
2.89M
EBT including unusual items
5.71M
19.41M
17.69M
6.10M
EBT excluding unusual items
-5.90M
19.66M
21.75M
20.68M
Income tax expense
16.97M
7.38M
4.21M
4.69M
Effective tax rate
296.96%
38.03%
23.82%
76.90%
Other operating expenses
3.52M
9.92M
3.29M
4.11M
Net income
-12.06M
12.88M
9.08M
-1.25M
Net profit margin
-2.17%
3.05%
2.14%
-0.31%
Earnings per share
-
-
-
-
Interest and investment income
4.08M
2.07M
716.57K
2.41M
Interest expense
-3.10M
-2.37M
-55.63K
-2.34M
Net interest expenses
983.79K
-305.41K
660.94K
66.83K
Depreciation and amortization charges
-
-
-
-
EBITDA
12.75M
40.38M
41.62M
36.30M
Gain or loss from assets sale
-227.96K
-
-51.12K
51.12K
Upcoming events
AI content may include mistakes. Learn more
Google apps